Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
11/07/2001 | EP1150974A1 Heterocyclic derivatives as inhibitors of factor xa |
11/07/2001 | EP1150973A1 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents |
11/07/2001 | EP1150972A1 Triazole and tetrazole derivatives, and their therapeutic use |
11/07/2001 | EP1150971A1 Piperidine and piperazine derivatives as inhibitors of the abeta fibril formation |
11/07/2001 | EP1150969A1 Alpha-azacyclomethyl quinoline derivatives for treating urinary incontinence |
11/07/2001 | EP1150963A1 Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them |
11/07/2001 | EP1150958A1 Substituted pyrazole carboxylic acids used to combat anaemias |
11/07/2001 | EP1150954A1 Anti-imflammatory indole derivatives |
11/07/2001 | EP1150952A1 Indole derivatives and their use as mcp-1 receptor antagonists |
11/07/2001 | EP1150948A1 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa |
11/07/2001 | EP0843679B1 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives |
11/07/2001 | EP0655996B1 Substituted benzylamino nitrogen containing non-aromatic heterocycles |
11/07/2001 | EP0546108B1 Pro-drugs for cck antagonists |
11/07/2001 | CN1321154A Propanolamine derivs. substd. with heteocyclic compound, methods for their production, pharmaceutical compositions contg. said compounds and use thereof |
11/07/2001 | CN1321151A Chemical compounds |
11/07/2001 | CN1321150A Amide derivs. useful as inhibitors of production of cytokines |
11/07/2001 | CN1320426A Compound for treatment of female sexual dysfuction |
11/07/2001 | CN1074413C Novel benzimidazole derivs. having CGMP-phosphodisterase inhibiting activity |
11/06/2001 | US6313312 3-Azabicyclo[3.1.0]hexane derivatives useful in therapy |
11/06/2001 | US6313310 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles |
11/06/2001 | US6313303 2-((pyridin-2-yl)-methylsulfinyl)-1h-benzimidazole derivative is produced by oxidizing the thioether using perborate, n-halosuccinimide, 1,3-dihalo-5,5-dimethylhydantoin, or dichloroisocyanurate; catalysis; synthesis of omeprazole, pantoprazole, rabeprazole, lansoprazole |
11/06/2001 | US6313302 Opioid kappa receptor antagonists; side effect reduction; analgesics, antiinflammatory agents, anesthetics, and neuroprotectants |
11/06/2001 | US6313298 Spiro-indolines as Y5 receptor antagonists |
11/06/2001 | US6313296 2-pyrrolidinone-1-acetic acid derivatives; viricides for human immunodeficiency virus (hiv); acquired immune deficiency syndrome (aids) treatment |
11/06/2001 | US6313164 Dithiolin derivatives, their preparation and their therapeutic effect |
11/06/2001 | US6313149 Diaminopyrazoles |
11/06/2001 | US6313148 For therapy of pain pain associated with joint conditions such as rheumatoid arthritis and osteoarthritis, postoperative pain, post-partum pain, the pain associated with dental conditions such as dental caries and gingivitis |
11/06/2001 | US6313145 Indoline derivatives useful as 5-HT-2C receptor antagonists |
11/06/2001 | US6313143 Substituted pyrroles |
11/06/2001 | US6313142 Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline |
11/06/2001 | US6313141 2-aminoalkylaminoquinolines as dopamine D4 ligands |
11/06/2001 | US6313127 For therapy of hypercholesterolemia or atherosclerosis |
11/06/2001 | US6313126 For threrapy of disorders associated with dysfunction in serotonergic neurotransmission, including depression and anxiety |
11/06/2001 | US6313122 As inhibitors of factor xa and are used as anticoagulants in mammals |
11/06/2001 | US6313120 Treatment or prevention of diseases involving bradykinin receptors |
11/06/2001 | US6313097 Treatment or prophylaxis of migraine or cluster headaches, non-insulin-dependent diabetes mellitus, inflammation, allergic rhinitis, asthma, morphine tolerance, menopausal hot flashes, diseases characterized by excessive vasodilatation |
11/06/2001 | US6312723 Compounds used in inhibiting gastric acid secretion 6-methoxy-2-(((4-methoxy-3, 5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1h-benzimidazole in tablet or capsule form with cyclodextrin |
11/06/2001 | US6312712 Benzimidazole and cyclodextrin for gastric acid related diseases |
11/06/2001 | US6312478 Two component kit; one component is a colorant comprising a monomethine or polymethine dye; second component consisting of a decolorizing agent |
11/06/2001 | CA2193178C Matrix metalloprotease inhibitors |
11/06/2001 | CA1341314C Derivatives of benzimidazole, benzothiazole and benzoxazole |
11/01/2001 | WO2001081342A2 Novel epothilone derivatives, method for the preparation thereof and their pharmaceutical use |
11/01/2001 | WO2001081338A1 Substituted sulfonylaminopyrimidines |
11/01/2001 | WO2001081337A1 Inhibitors of dipeptidyl peptidase iv |
11/01/2001 | WO2001081335A1 Pyrimidine-sulfonamides having endothelin-antagonist activity |
11/01/2001 | WO2001081334A2 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands |
11/01/2001 | WO2001081326A1 Substituted 1-aza-2-imino-heterocycles and their use as nicotinic acetylcholine receptors activators |
11/01/2001 | WO2001081322A1 Non-imidazole benzodiazepine inhibitors of farnesyl protein transferase |
11/01/2001 | WO2001081316A2 Substituted phenyl farnesyltransferase inhibitors |
11/01/2001 | WO2001081314A1 Naphthamidine urokinase inhibitors |
11/01/2001 | WO2001081311A1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis |
11/01/2001 | WO2001081310A1 1-aroyl-piperidinyl benzamidines |
11/01/2001 | WO2001081308A2 Aminopiperidines for use as glyt-1 inhibitors |
11/01/2001 | WO2001081304A1 Inhibitors of dipeptidyl peptidase iv |
11/01/2001 | WO2001081303A1 Pyrrolidine and piperidine derivatives and their use for the treament of neurodegenerative disorders |
11/01/2001 | WO2001080858A1 Stable liquid preparation |
11/01/2001 | WO2001080844A2 Method of treating dry eye disease with nicotinic acetylcholine receptor agonists |
11/01/2001 | WO2001044239A3 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
11/01/2001 | WO2001029025A3 Tyrosine kinase inhibitors |
11/01/2001 | WO2001010847A3 Novel integrin receptor antagonists |
11/01/2001 | US20010037030 Tricyclic amine derivatives |
11/01/2001 | US20010037025 Benzopyran, benzothiopyran or benzoquinone derivatives are useful in the treatment of ailments and disorders where a reduction of blood glucose is benefical, such as diabetes |
11/01/2001 | US20010037023 Alkyl pyrimidines substituted piperidine derivatives are used as tachykinin antagonsit, useful in the treatment of pain, depression, anxiety, panic, schizophrenia, neuralgia, addiction disorder, inflammation, and neurological disorders |
11/01/2001 | US20010037011 Reacting a carboxylic acid with an amine carboxylate salt, in presence of inorganic base, wherein the salt product of inorganic base cation and the carboxylate anion has a solubility in water of polar solvent less or equal 5/100 |
11/01/2001 | US20010036952 Treatment of alopecia |
11/01/2001 | US20010036947 Pipecolic acid derivative hair growth compositions and uses |
11/01/2001 | US20010036946 Antiinflammatory agents |
11/01/2001 | US20010036945 Certain Isoquinolinamine and phthalazinamine derivatives; corticotropin-releasing factor receptor CRF1 specific ligands |
11/01/2001 | US20010036942 Nervous system disorders |
11/01/2001 | CA2407663A1 Inhibitors of dipeptidyl peptidase iv |
11/01/2001 | CA2407662A1 Inhibitors of dipeptidyl peptidase iv |
11/01/2001 | CA2407093A1 Substituted phenyl farnesyltransferase inhibitors |
11/01/2001 | CA2406652A1 Aminopiperidines for use as glyt-1 inhibitors |
11/01/2001 | CA2372673A1 Cyclic amidine compounds |
11/01/2001 | CA2365320A1 Novel heterocyclic compounds |
10/31/2001 | EP1149580A1 Use of heteroaryl substituted N-(Indole-2-Carbonyl-) amides for the manufacture of a medicament for the treatment of infection |
10/31/2001 | EP1149092A2 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles |
10/31/2001 | EP1149091A1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
10/31/2001 | EP1149090A1 Potassium salt of ($i(s))-omeprazole |
10/31/2001 | EP1148879A2 Use of pyrazole carboxamides |
10/31/2001 | EP1148875A1 Methods and compositions to enhance white blood cell count |
10/31/2001 | EP1148783A1 Converting cox inhibition compounds that are not cox-2 selective inhibitors to derivatives that are cox-2 selective inhibitors |
10/31/2001 | EP1108720A9 Herbicidal 2-Pyrazolyl-6-Aryloxy-Pyri(mi)dines |
10/31/2001 | EP0800524B1 6-[triazolyl[ 3-(trifluoromethyl)phenyl]methyl]-2-quinolinones and -quinolinethiones |
10/31/2001 | EP0787131B1 Benzenesulphonamide derivatives as bradykinine antagonists |
10/31/2001 | EP0773929B1 Piperidine derivatives as neurokinin antagonists |
10/31/2001 | EP0767782B1 Aryl and heteroaryl alkoxynaphthalene derivatives |
10/31/2001 | EP0754180B1 Anti-helicobacter ester and carbamate derivatives of azolones |
10/31/2001 | EP0719258B1 Cyclic amide derivatives for protecting against ultraviolet rays |
10/31/2001 | DE10021246A1 New N-substituted benzamide derivatives are tyrosine kinase KDR and FLT inhibitors useful e.g. for treating tumors, psoriasis, rheumatoid arthritis, diabetic retinopathy or liver sclerosis |
10/31/2001 | CN1320123A Disubstituted maleimide compounds and medicinal utilization thereof |
10/31/2001 | CN1320121A Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
10/31/2001 | CN1320119A Sulfonyltriazol derivatives and their use for combating micro-organisms |
10/31/2001 | CN1320118A Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
10/31/2001 | CN1320037A Antiviral indoleoxoacetyl piperazine derivatives |
10/31/2001 | CN1320028A Method of treating hair loss using sulfonamides |
10/31/2001 | CN1319599A Process for preparing imidazolinone |
10/31/2001 | CN1319594A Diazesuberane derivant or its salt |
10/31/2001 | CN1319590A 2,2,6,6, diethyl-dimethy-1-alkoxy-piperidine compound and 1-oxide |
10/31/2001 | CN1073988C Substituted N-heteroaroylguanidin, preparation, pharmaceutical application and medicine containg same |